Search

everythinglearnresearchcommunity

for

Search:↓

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

High levels of androgens during early development may cause PCOS-like symptoms.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Early balding men may have insulin resistance, but lifestyle changes can help.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Mice with LSS deficiency showed hair loss and cataracts, similar to humans, and can help in understanding and treating this condition.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Small molecule IM boosts hair growth by changing stem cell metabolism.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Hair loss may indicate higher heart risk and metabolic issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Finasteride affects brain stress and enzyme activity differently in various regions, possibly helping with liver-related brain issues.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.